Access cutting-edge heart disease treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access heart disease specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart disease treatment provided free
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke. The study drug will be administered subcutaneously (SC) (under the skin). Approximately 1700 additional participants will be enrolled in an addendum to explore Lp(a) lowering with an alternative dosing schema.
Sponsor: Eli Lilly and Company
Check if you qualify for this heart disease clinical trial in Birmingham, AL
If you're searching for heart disease treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.